<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01082744</url>
  </required_header>
  <id_info>
    <org_study_id>2009.558</org_study_id>
    <secondary_id>2009-014832-38</secondary_id>
    <nct_id>NCT01082744</nct_id>
  </id_info>
  <brief_title>Thoracic Paravertebral Block for Postoperative Analgesia After Video-assisted Thoracic Surgery.</brief_title>
  <acronym>PARAVI</acronym>
  <official_title>Thoracic Paravertebral Block: a Comparative Study of Ropivacaine With Ropivacaine and Sufentanil for Treating Pain After Video-assisted Thoracic Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The use of paravertebral catheters is a recommended technique to achieve postoperative
      analgesia after thoracic surgery. To date there is no consensus on which drug regime (local
      anesthetics with or without opioid) is best. The aim of this prospective clinical trial is to
      determine wether the use of ropivacaine and sufentanil injected through a thoracic
      paravertebral catheter results in decreased acute postoperative pain compared with plain
      ropivacaine in patients after thoracoscopic lung surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>morphine consumption during the first 48 hours</measure>
    <time_frame>48 hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Acute pain</measure>
    <time_frame>48 hours</time_frame>
    <description>using the Visual Analogue Scale (VAS) score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Biological measurements</measure>
    <time_frame>48 hours</time_frame>
    <description>Oxygen saturation, level of sedation, respiratory rate, nausea, vomiting, itching, urine retention, blood pressure, heart rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>48 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Chronic pain</measure>
    <time_frame>3 and 6 monthes</time_frame>
    <description>assessed with the Saint-Antoine Pain Questionnaire (French version of the Mac Gill Pain Questionnaire) and the DN4 questionnaire.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Continuous paravertebral block with ropivacaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous paravertebral block with ropivacaine and sufentanil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine + Sufentanil</intervention_name>
    <description>Sufentanil at 0.25 Âµg/ml added to ropivacaine at 2 mg/ml at a perfusion rate of 0.15 ml/kg/h for continuous paravertebral block over 48 hours</description>
    <arm_group_label>Continuous paravertebral block with ropivacaine and sufentanil</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>Ropivacaine at 2 mg/ml at a perfusion rate of 0.15 ml/kg/h for continuous paravertebral block over 48 hours</description>
    <arm_group_label>Continuous paravertebral block with ropivacaine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient scheduled for planned video-assisted thoracic surgery

          -  Patient that consent to participate

          -  Planned placement of paravertebral catheter

          -  Patient having a medical insurance

        Exclusion Criteria:

          -  Patient less than 18 years

          -  Refusal to participate

          -  Known pregnancy

          -  Known allergies to local anesthetics, sufentanil and /or to iodinated contrast
             material

          -  Intolerance to sufentanil and/or morphine

          -  Chronic consumption of opiates

          -  Preoperative chronic pain syndrome

          -  Patient having a contraindication to placement of paravertebrtal catheter
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christian BAUER, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospices Civils de Lyon, Hopital Louis Pradel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospices Civils de Lyon, Hopital Louis Pradel, Department of Anesthesiology</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 8, 2010</study_first_submitted>
  <study_first_submitted_qc>March 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 9, 2010</study_first_posted>
  <last_update_submitted>March 18, 2015</last_update_submitted>
  <last_update_submitted_qc>March 18, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 19, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Paravertebral Block</keyword>
  <keyword>Regional Anesthesia</keyword>
  <keyword>Anesthetics Local</keyword>
  <keyword>Ropivacaine</keyword>
  <keyword>Sufentanil</keyword>
  <keyword>Pain Postoperative</keyword>
  <keyword>Chronic Pain</keyword>
  <keyword>Thoracic Surgery Video-Assisted.</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

